1547. Integrating Long-acting Injectable Cabotegravir for PrEP into Standard of Care for Cisgender Women, Transgender Women, Transgender Men, and Men Who Have Sex with Men: Results from the PILLAR & EBONI Studies

BACKGROUND: EBONI and PILLAR are Phase IV implementation science trials evaluating the integration of long-acting injectable Cabotegravir for PrEP (CAB LA) into standard of care at 37 clinics across the U.S. EBONI enrolls Black cisgender/transgender women and PILLAR enrolls men who have sex with men...

Descripción completa

Detalles Bibliográficos
Autores principales: Valenti, William M, Phoenix, John, Patel, Rupa R, Tims-Cook, Zandraetta, Pilgrim, Nanlesta, Haley, Amber, Sutton, Kenneth, Gaudion, Alison, Merrill, Deanna, Urbaityte, Rimgaile, Li, Bo, Andrae, David, Bonner, Courtney, Herbst, Abigail, Chowdhury, Dhuly, Garges, Harmony, Czarnogorski, Maggie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678178/
http://dx.doi.org/10.1093/ofid/ofad500.1382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678178/
http://dx.doi.org/10.1093/ofid/ofad500.1382

Ejemplares similares